CD44 and hepatocellular carcinoma: CAFs isolated from freshly resected HCC tumor tissues have shown MSC-like characteristics, as assessed by enhanced clonogenic potential and upregulation of CD73, CD90, CD105, CD44, CD13, CD29, and CD166 expression and downregulation of CD31, CD34, CD45, CD117, and HLA-DR expression.